Previous 10 | Next 10 |
PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify ESCC patients Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s PD-L1 IHC 22C3 pharmDx assay for expanded use. The assay is now approved...
This article is part of a series that provides an ongoing analysis of the changes made to William von Mueffling’s 13F stock portfolio on a quarterly basis. It is based on von Mueffling’s regulatory 13F Form filed on 07/26/2019. Please visit our Tracking William Von Mueffling's...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
Agilent Technologies Inc. (NYSE: A) will release third-quarter fiscal 2019 financial results after the stock market closes on August 14. The company will also host a live webcast of its investor conference call in listen-only mode. Date: Wednesday, August 14, 2019 Time: 1:30 PM (Pacific ...
Introduction: Since spinning off from Hewlett Packard 20 years ago in 1999, Agilent has transformed from a conglomerate of testing and measurement businesses serving a wide variety of end markets into a much more focused player. They spun-off Verigy in 2006 and Keysight in 2014 (click her...
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...
Millendo Therapeutics (NASDAQ: MLND ) initiated with Outperform rating and $26 (141% upside) at Oppenheimer. More news on: Viking Therapeutics, Inc., Millendo Therapeutics, Inc., Laboratory Corporation of America Holdings, Healthcare stocks news, Stocks on the move, , Read more ...
Agilent Technologies (A) has made a bolt-on deal as it is buying some real growth with the purchase of BioTek Instruments in a deal which looks fair. As the bolt-on deal looks reasonable, can easily be financed, given the strong finances, and does provide a boost to organic growth rates, I r...
Akero Therapeutics (NASDAQ: AKRO ) initiated with Buy rating and $28 (41% upside) price target at Jefferies. Shares down a fraction premarket. More news on: Akero Therapeutics, Inc., Atreca, Inc., Personalis, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
MAGE-A4 IHC 1F9 pharmDx is indicated as an aid in identifying patients with synovial sarcoma for whom TECELRA ® , a MAGE-A4-directed engineered T-Cell Receptor (TCR) therapy is being considered Agilent Technologies Inc. , (NYSE: A) today announced that it has received FDA a...
2024-08-01 15:15:03 ET William Blair analyst issues OUTPERFORM recommendation for A on August 1, 2024 01:31PM ET. The previous analyst recommendation was Outperform. A was trading at $143.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...